Lead Product(s) : Sobetirome
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
$100,000 Gift Speeds Exploration of Sobetirome as COVID-19 Treatment
Details : Phase II clinical trials of sobetirome aims to address the lung injury component of COVID-19-induced acute respiratory distress syndrome (ARDS) to halt disease progression.
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 16, 2020
Lead Product(s) : Sobetirome
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Preclinical
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
